vs

Side-by-side financial comparison of Arteris, Inc. (AIP) and CuriosityStream Inc. (CURI). Click either name above to swap in a different company.

Arteris, Inc. is the larger business by last-quarter revenue ($20.1M vs $19.2M, roughly 1.0× CuriosityStream Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -42.2%, a 22.5% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs 30.0%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $3.0M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 24.7%).

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

AIP vs CURI — Head-to-Head

Bigger by revenue
AIP
AIP
1.0× larger
AIP
$20.1M
$19.2M
CURI
Growing faster (revenue YoY)
CURI
CURI
+5.8% gap
CURI
35.8%
30.0%
AIP
Higher net margin
CURI
CURI
22.5% more per $
CURI
-19.7%
-42.2%
AIP
More free cash flow
CURI
CURI
$908.0K more FCF
CURI
$3.9M
$3.0M
AIP
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
24.7%
AIP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AIP
AIP
CURI
CURI
Revenue
$20.1M
$19.2M
Net Profit
$-8.5M
$-3.8M
Gross Margin
90.8%
Operating Margin
-42.0%
-17.6%
Net Margin
-42.2%
-19.7%
Revenue YoY
30.0%
35.8%
Net Profit YoY
-3.7%
-34.6%
EPS (diluted)
$-0.19
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIP
AIP
CURI
CURI
Q4 25
$20.1M
$19.2M
Q3 25
$17.4M
$18.4M
Q2 25
$16.5M
$19.0M
Q1 25
$16.5M
$15.1M
Q4 24
$15.5M
$14.1M
Q3 24
$14.7M
$12.6M
Q2 24
$14.6M
$12.4M
Q1 24
$12.9M
$12.0M
Net Profit
AIP
AIP
CURI
CURI
Q4 25
$-8.5M
$-3.8M
Q3 25
$-9.0M
$-3.7M
Q2 25
$-9.1M
$784.0K
Q1 25
$-8.1M
$319.0K
Q4 24
$-8.2M
$-2.8M
Q3 24
$-7.7M
$-3.1M
Q2 24
$-8.3M
$-2.0M
Q1 24
$-9.4M
$-5.0M
Gross Margin
AIP
AIP
CURI
CURI
Q4 25
90.8%
Q3 25
89.9%
Q2 25
89.4%
Q1 25
90.8%
Q4 24
89.8%
Q3 24
90.1%
Q2 24
90.0%
Q1 24
88.7%
Operating Margin
AIP
AIP
CURI
CURI
Q4 25
-42.0%
-17.6%
Q3 25
-50.1%
-24.5%
Q2 25
-50.0%
2.5%
Q1 25
-46.6%
0.5%
Q4 24
-45.9%
-27.4%
Q3 24
-53.8%
-25.8%
Q2 24
-51.1%
-20.6%
Q1 24
-70.5%
-30.4%
Net Margin
AIP
AIP
CURI
CURI
Q4 25
-42.2%
-19.7%
Q3 25
-51.6%
-20.4%
Q2 25
-55.3%
4.1%
Q1 25
-49.1%
2.1%
Q4 24
-53.0%
-19.9%
Q3 24
-52.2%
-24.3%
Q2 24
-57.2%
-16.4%
Q1 24
-72.6%
-42.0%
EPS (diluted)
AIP
AIP
CURI
CURI
Q4 25
$-0.19
$-0.07
Q3 25
$-0.21
$-0.06
Q2 25
$-0.22
$0.01
Q1 25
$-0.20
$0.01
Q4 24
$-0.19
$-0.05
Q3 24
$-0.20
$-0.06
Q2 24
$-0.22
$-0.04
Q1 24
$-0.25
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIP
AIP
CURI
CURI
Cash + ST InvestmentsLiquidity on hand
$33.9M
$27.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-14.6M
$41.5M
Total Assets
$115.0M
$75.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIP
AIP
CURI
CURI
Q4 25
$33.9M
$27.3M
Q3 25
$39.0M
$27.8M
Q2 25
$38.0M
$28.1M
Q1 25
$42.3M
$33.4M
Q4 24
$43.8M
$32.1M
Q3 24
$48.7M
$33.2M
Q2 24
$45.8M
$39.5M
Q1 24
$44.8M
$38.8M
Stockholders' Equity
AIP
AIP
CURI
CURI
Q4 25
$-14.6M
$41.5M
Q3 25
$-11.4M
$47.2M
Q2 25
$-7.5M
$49.8M
Q1 25
$-4.8M
$58.1M
Q4 24
$-1.2M
$57.8M
Q3 24
$2.2M
$62.2M
Q2 24
$5.3M
$64.8M
Q1 24
$9.5M
$67.0M
Total Assets
AIP
AIP
CURI
CURI
Q4 25
$115.0M
$75.7M
Q3 25
$107.7M
$74.7M
Q2 25
$106.9M
$78.7M
Q1 25
$98.3M
$85.3M
Q4 24
$106.1M
$86.2M
Q3 24
$97.7M
$87.6M
Q2 24
$96.4M
$90.9M
Q1 24
$101.4M
$94.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIP
AIP
CURI
CURI
Operating Cash FlowLast quarter
$3.2M
$4.0M
Free Cash FlowOCF − Capex
$3.0M
$3.9M
FCF MarginFCF / Revenue
15.1%
20.5%
Capex IntensityCapex / Revenue
0.7%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIP
AIP
CURI
CURI
Q4 25
$3.2M
$4.0M
Q3 25
$3.2M
$4.4M
Q2 25
$-2.5M
$2.8M
Q1 25
$2.9M
$1.9M
Q4 24
$-2.6M
$3.0M
Q3 24
$1.1M
$2.3M
Q2 24
$311.0K
$2.2M
Q1 24
$477.0K
$666.0K
Free Cash Flow
AIP
AIP
CURI
CURI
Q4 25
$3.0M
$3.9M
Q3 25
$2.5M
Q2 25
$-2.8M
Q1 25
$2.7M
$1.8M
Q4 24
$-2.7M
Q3 24
$1.1M
Q2 24
$264.0K
Q1 24
$281.0K
FCF Margin
AIP
AIP
CURI
CURI
Q4 25
15.1%
20.5%
Q3 25
14.2%
Q2 25
-17.2%
Q1 25
16.2%
12.2%
Q4 24
-17.3%
Q3 24
7.4%
Q2 24
1.8%
Q1 24
2.2%
Capex Intensity
AIP
AIP
CURI
CURI
Q4 25
0.7%
0.1%
Q3 25
4.1%
0.0%
Q2 25
2.2%
0.0%
Q1 25
1.1%
0.5%
Q4 24
0.3%
0.0%
Q3 24
0.2%
0.0%
Q2 24
0.3%
0.0%
Q1 24
1.5%
0.0%
Cash Conversion
AIP
AIP
CURI
CURI
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIP
AIP

License And Maintenance$17.5M87%
Variable Royalties And Other$2.6M13%

CURI
CURI

Segment breakdown not available.

Related Comparisons